Confirmed Worsening in the Symbol Digit Modalities Test and Timed 25-Foot Walk in Routine Multiple Sclerosis Care: A Retrospective Single-Center Longitudinal Study
{"title":"Confirmed Worsening in the Symbol Digit Modalities Test and Timed 25-Foot Walk in Routine Multiple Sclerosis Care: A Retrospective Single-Center Longitudinal Study","authors":"Kazuhiro Horiuchi, Shuntaro Nakamura, Kaede Ishikawa, Sumire Nunomura, Kazuki Yamada, Takashi Inoue, Kei Oiwa, Shintaro Fujii, Yuki Oshima, Akihiko Kudo, Ichiro Yabe","doi":"10.1111/cen3.70065","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Performance-based monitoring in multiple sclerosis (MS) is widely used, yet objective deterioration in routine regional practice is not well quantified. We aimed to estimate 24-month trajectories of cognitive processing speed and ambulation and to quantify confirmed worsening in these performance measures.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We performed a retrospective, single-center longitudinal study of 59 patients with repeated Symbol Digit Modalities Test (SDMT) and/or Timed 25-Foot Walk (T25FW) assessments. Linear mixed-effects models with random intercepts estimated marginal means at 0, 6, 12, 18, and 24 months, adjusting for prespecified covariates. T25FW was modeled on the log scale; unmeasurable T25FW was summarized separately. Confirmed performance worsening was defined as at least a 4-point SDMT decline or at least a 20% T25FW increase from baseline, confirmed at a reassessment at least 6 months later. Inference was restricted to 0–24 months.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Mean changes over 24 months were small, but observed paired changes varied widely. Confirmed performance worsening occurred in 7/59 patients (11.9%) for SDMT and 8/56 (14.3%) for T25FW (among those measurable at baseline). Unmeasurable T25FW was present in 3/59 (5.1%) at baseline and occurred during follow-up in 2/56 (3.6%) of baseline-measurable patients.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In routine regional MS care, approximately one in eight patients met criteria for confirmed worsening in SDMT or T25FW during the 24-month observation period despite modest mean trends. Longitudinal monitoring should also capture transitions to unmeasurable walking status.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":"17 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.70065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Performance-based monitoring in multiple sclerosis (MS) is widely used, yet objective deterioration in routine regional practice is not well quantified. We aimed to estimate 24-month trajectories of cognitive processing speed and ambulation and to quantify confirmed worsening in these performance measures.
Methods
We performed a retrospective, single-center longitudinal study of 59 patients with repeated Symbol Digit Modalities Test (SDMT) and/or Timed 25-Foot Walk (T25FW) assessments. Linear mixed-effects models with random intercepts estimated marginal means at 0, 6, 12, 18, and 24 months, adjusting for prespecified covariates. T25FW was modeled on the log scale; unmeasurable T25FW was summarized separately. Confirmed performance worsening was defined as at least a 4-point SDMT decline or at least a 20% T25FW increase from baseline, confirmed at a reassessment at least 6 months later. Inference was restricted to 0–24 months.
Results
Mean changes over 24 months were small, but observed paired changes varied widely. Confirmed performance worsening occurred in 7/59 patients (11.9%) for SDMT and 8/56 (14.3%) for T25FW (among those measurable at baseline). Unmeasurable T25FW was present in 3/59 (5.1%) at baseline and occurred during follow-up in 2/56 (3.6%) of baseline-measurable patients.
Conclusion
In routine regional MS care, approximately one in eight patients met criteria for confirmed worsening in SDMT or T25FW during the 24-month observation period despite modest mean trends. Longitudinal monitoring should also capture transitions to unmeasurable walking status.